You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial
|
---|---|
Published in |
BMC Musculoskeletal Disorders, November 2012
|
DOI | 10.1186/1471-2474-13-229 |
Pubmed ID | |
Authors |
Giuseppe Filardo, Elizaveta Kon, Alessandro Di Martino, Berardo Di Matteo, Maria Letizia Merli, Annarita Cenacchi, Pier Maria Fornasari, Maurilio Marcacci |
Abstract |
Platelet rich plasma (PRP), a blood-derived product rich in growth factors, is a promising treatment for cartilage defects but there is still a lack of clinical evidence. The aim of this study is to show, through a randomized double blind prospective trial, the efficacy of this procedure, by comparing PRP to Hyaluronic Acid (HA) injections for the treatment of knee chondropathy or osteoarthritis (OA). |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 33% |
Chile | 1 | 17% |
United Kingdom | 1 | 17% |
Andorra | 1 | 17% |
Unknown | 1 | 17% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 67% |
Practitioners (doctors, other healthcare professionals) | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 379 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | <1% |
United Kingdom | 3 | <1% |
Spain | 2 | <1% |
Korea, Republic of | 1 | <1% |
Greece | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 368 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 52 | 14% |
Student > Master | 50 | 13% |
Other | 37 | 10% |
Student > Bachelor | 31 | 8% |
Student > Doctoral Student | 30 | 8% |
Other | 88 | 23% |
Unknown | 91 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 175 | 46% |
Nursing and Health Professions | 21 | 6% |
Biochemistry, Genetics and Molecular Biology | 14 | 4% |
Agricultural and Biological Sciences | 12 | 3% |
Engineering | 11 | 3% |
Other | 40 | 11% |
Unknown | 106 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2014.
All research outputs
#6,114,131
of 22,687,320 outputs
Outputs from BMC Musculoskeletal Disorders
#1,146
of 4,028 outputs
Outputs of similar age
#63,271
of 276,424 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#13
of 82 outputs
Altmetric has tracked 22,687,320 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 4,028 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,424 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.